Researchers examining electronic health record data found nirsevimab administration was associated with reduced antibiotic prescribing among infants during their first respiratory syncytial virus (RSV) season, as published in Clinical Infectious Diseases. Among 15,341 eligible infants from 32 pediatric practices in the study, 7,413 (48.3%) received nirsevimab. At 6 months, nirsevimab was associated with a 14.4% reduction in antibiotic prescribing for outpatient acute respiratory tract infections and a 40.3% reduction for outpatient bronchiolitis. Antibiotic prescribing associated …
Read More